2 completed, 1 active not recruiting, 1 recruiting. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Active not recruiting 1, Recruiting 1 |
Follow VP-102: new trials by email Literature Review of VP-102 trials Research Report on VP-102
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3) VP-102 (US) / TO-208 (Japan), Vehicle (US) / Vehicle (Japan) - Common Warts, Common Warts (Verruca Vulgaris) | Phase 3 | Recruiting | Verrica Pharmaceuticals Inc. | 300 | 2026-06-15 | 2026-09-03 |
| Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2) VP-102, Vehicle - Common Warts, Common Warts (Verruca Vulgaris) | Phase 3 | Active not recruiting | Verrica Pharmaceuticals Inc. | 302 | 2025-12-17 | 2026-10-23 |
| Cantharidin Application in Molluscum Patients-1 VP-102 - Cantharidin, Topical Film Forming Solution, Placebo -Topical Film Forming Solution without VP-102 - Molluscum Contagiosum | Phase 3 | Completed | Verrica Pharmaceuticals Inc. | 266 | 2018-03-21 | 2022-01-11 |
| Cantharidin Application in Molluscum Patients VP-102 - Cantharidin, Topical Film Forming Solution, Placebo -Topical Film Forming Solution without VP-102 - Molluscum Contagiosum | Phase 3 | Completed | Verrica Pharmaceuticals Inc. | 262 | 2018-02-14 | 2021-12-14 |
Cellulitis (2) · Molluscum Contagiosum (2) · Poxviridae Infections (2) · Skin Diseases (2) · Skin Diseases, Viral (2) · Warts (2)
Verrica Pharmaceuticals Inc. (4)
United States (4) · Japan (1)